These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 10460171)

  • 41. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
    Wybenga-Groot LE; McGlade CJ
    Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Csk phosphorylation and inactivation in vitro by the cAMP-dependent protein kinase.
    Sun G; Ke S; Budde RJ
    Arch Biochem Biophys; 1997 Jul; 343(2):194-200. PubMed ID: 9224730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding.
    Broome MA; Hunter T
    Oncogene; 1997 Jan; 14(1):17-34. PubMed ID: 9010229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394.
    Bougeret C; Delaunay T; Romero F; Jullien P; Sabe H; Hanafusa H; Benarous R; Fischer S
    J Biol Chem; 1996 Mar; 271(13):7465-72. PubMed ID: 8631775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
    Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
    Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of Batk, a predominantly brain-specific non-receptor protein tyrosine kinase related to Csk.
    Kuo SS; Moran P; Gripp J; Armanini M; Phillips HS; Goddard A; Caras IW
    J Neurosci Res; 1994 Aug; 38(6):705-15. PubMed ID: 7807586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the binding of the Src homology 2 domain of Csk to tyrosine-phosphorylated proteins in the suppression and mitotic activation of c-Src.
    Sabe H; Hata A; Okada M; Nakagawa H; Hanafusa H
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3984-8. PubMed ID: 7513429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conserved hydrophobicity in the SH2-kinase linker is required for catalytic activity of Csk and CHK.
    Mikkola ET; Bergman M
    FEBS Lett; 2003 Jun; 544(1-3):11-4. PubMed ID: 12782282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure of the carboxyl-terminal Src kinase, Csk.
    Ogawa A; Takayama Y; Sakai H; Chong KT; Takeuchi S; Nakagawa A; Nada S; Okada M; Tsukihara T
    J Biol Chem; 2002 Apr; 277(17):14351-4. PubMed ID: 11884384
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine.
    Lamers MB; Antson AA; Hubbard RE; Scott RK; Williams DH
    J Mol Biol; 1999 Jan; 285(2):713-25. PubMed ID: 9878439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Obtaining a full-length encoding cDNA of Csk family tyrosine kinase from human lymphocytes].
    Emel'ianova VP; Baranova LA; Zhornik EV; Naumenko LV; Birich TA; Volotovskiĭ ID
    Mol Biol (Mosk); 2007; 41(4):654-8. PubMed ID: 17936985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spontaneous autophosphorylation of Lyn tyrosine kinase at both its activation segment and C-terminal tail confers altered substrate specificity.
    Donella-Deana A; Cesaro L; Ruzzene M; Brunati AM; Marin O; Pinna LA
    Biochemistry; 1998 Feb; 37(5):1438-46. PubMed ID: 9477973
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interaction between Btk TH and SH3 domain.
    Okoh MP; Vihinen M
    Biopolymers; 2002 Apr; 63(5):325-34. PubMed ID: 11877742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural basis of the auto-inhibition mechanism of nonreceptor tyrosine kinase PTK6.
    Ko S; Ahn KE; Lee YM; Ahn HC; Lee W
    Biochem Biophys Res Commun; 2009 Jun; 384(2):236-42. PubMed ID: 19401189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystal structure of the Src family tyrosine kinase Hck.
    Sicheri F; Moarefi I; Kuriyan J
    Nature; 1997 Feb; 385(6617):602-9. PubMed ID: 9024658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
    Gonfloni S; Williams JC; Hattula K; Weijland A; Wierenga RK; Superti-Furga G
    EMBO J; 1997 Dec; 16(24):7261-71. PubMed ID: 9405355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular cloning of lsk, a carboxyl-terminal src kinase (csk) related gene, expressed in leukocytes.
    McVicar DW; Lal BK; Lloyd A; Kawamura M; Chen YQ; Zhang X; Staples JE; Ortaldo JR; O'Shea JJ
    Oncogene; 1994 Jul; 9(7):2037-44. PubMed ID: 7516063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel disulfide bond in the SH2 Domain of the C-terminal Src kinase controls catalytic activity.
    Mills JE; Whitford PC; Shaffer J; Onuchic JN; Adams JA; Jennings PA
    J Mol Biol; 2007 Feb; 365(5):1460-8. PubMed ID: 17137590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.
    Superti-Furga G; Fumagalli S; Koegl M; Courtneidge SA; Draetta G
    EMBO J; 1993 Jul; 12(7):2625-34. PubMed ID: 7687537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.